- Article metrics
- Last updated: Wed, 15 Oct 2025 13:37:45 Z
Pilot study to evaLuate the role of high-dose rAnibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with perSistent/recurrenT macular fluid <30 days following treatment with intravitreal anti-VEGF therapy (the LAST Study)
Access & Citations
-
- 1876
- Article Accesses
-
- 59
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 1 tweeters
- 70 Mendeley
This article is in the 1st percentile (ranked 150,103rd) of the 167,363 tracked articles of a similar age in all journals and the 1st percentile (ranked 14th) of the 20 tracked articles of a similar age in Eye
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.